Natural Phyto Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2024)
- Profit 100.00%
(FY 2024)
- Ebitda 100.00%
(FY 2024)
- Net Worth
- Total Assets 8.04%
(FY 2024)
About Natural Phyto Pharma
The Corporate was formerly known as Natural Drug Discoveries Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Laxminarayana, Sushil Mundra, and Asha Srinivasan serve as directors at the Company.
- CIN/LLPIN
U73200KA2018PTC117070
- Company No.
117070
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2018
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Natural Phyto Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Laxminarayana  | Director | 29-Sep-2018 | Current |
| Asha Srinivasan | Director | 25-Mar-2022 | Current |
| Sushil Mundra | Director | 10-Nov-2019 | Current |
Financial Performance of Natural Phyto Pharma.
Natural Phyto Pharma Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 100% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Natural Phyto Pharma?
In 2024, Natural Phyto Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Natural Capsules LimitedActive 31 years 3 monthsSunil Laxminarayana and Sushil Mundra are mutual person
- Square Plus Life Sciences Private LimitedActive 10 years 10 months
Sunil Laxminarayana and Sushil Mundra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Natural Phyto Pharma?
Unlock and access historical data on people associated with Natural Phyto Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natural Phyto Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natural Phyto Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
